Chlorothiazide
Spezifikationen
58-94-6CAS-Nummer
200-404-9EG-Nummer
6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamideIUPAC-Name
C7H6ClN3O4S2Chemische Formel
295.7 g/molMolekulargewicht
chlorothiazide; 58-94-6; Diuril; Chlorthiazide; Chlorothiazid; Chlotride; Chlortiazid; Flumen; Chlorosal; Chlorurit; Clotride; Diuresal; Diurilix; Saluretil; Warduzide; Alurene; Diurite; Diutrid; Minzil; Salisan; Salunil; Saluric; Urinex; Yadalan; Neo-Dema; Sk-chlorothiazide; Chlorothiazidum; Clorotiazida; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; Clorotiazide; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; DTXSID0022800; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; NSC-25693; CHEBI:3640; NSC25693; 77W477J15H; DTXCID802800; 6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide; 6-chloro-1,1-dioxo-4H-1$l^(6),2,4-benzothiadiazine-7-sulfonamide; 6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo(1,2,4)thiadiazine-7-sulfonic acid amide; 6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide; RefChem:54795; C03AA04; 200-404-9; Thiazide; C7H6ClN3O4S2; component of Aldoclor; MFCD00058576; NSC 25693; Diuril (TN); MLS000028398; Chlorthiazid; Chlorthiazidum; CAS-58-94-6; NCGC00015242-04; Chloriazid; Chlrosal; SMR000058429; Clorotiazide [DCIT]; 6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide; Diuril Boluses; Diuril Boluses, Veterinary; Clorotiazida [INN-Spanish]; Chlorothiazidum [INN-Latin]; 6-chloro-1,1-dioxo-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide; 6-chloro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide; CCRIS 5999; HSDB 3030; SR-01000075604; EINECS 200-404-9; 6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide; Chlorothiazide (JAN/USP/INN); Chlorothiazide [USP:INN:BAN]; UNII-77W477J15H; Hydrochlorothiazide EP Impurity A; Chlorothiazide CRS; Prestwick_56; Diupres (Salt/Mix); Aldoclor (Salt/Mix); Spectrum_000134; Prestwick0_000251; Prestwick1_000251; Prestwick2_000251; Prestwick3_000251; Spectrum2_000154; Spectrum3_000342; Spectrum4_000280; Spectrum5_001446; Chlorothiazide (Standard); Lopac-C-4911; CHEMBL842; Epitope ID:613422; C 4911; CHLOROTHIAZIDE [MI]; cid_2720; CHLOROTHIAZIDE [INN]; CHLOROTHIAZIDE [JAN]; Lopac0_000254; SCHEMBL22329; SCHEMBL26200; BSPBio_000062; BSPBio_002003; CHLOROTHIAZIDE [HSDB]; KBioGR_000780; KBioSS_000594; orb134575; BIDD:GT0635; CHLOROTHIAZIDE [VANDF]; DivK1c_000675; SPECTRUM1500180; SPBio_000288; SPBio_002281; CHLOROTHIAZIDE [MART.]; BPBio1_000070; GTPL4835; orb2893744; orb3025788; CHLOROTHIAZIDE [WHO-DD]; SCHEMBL29465195; SCHEMBL30594143; BDBM39351; Chlorothiazide, thiazide diuretic; HMS502B17; HY-B0224R; KBio1_000675; KBio2_000594; KBio2_003162; KBio2_005730; KBio3_001223; NINDS_000675; HMS1568D04; HMS1920K15; HMS2091C18; HMS2095D04; HMS2232N22; HMS3259K15; HMS3260D10; HMS3370A15; HMS3655M13; HMS3712D04; HMS5079P04; Pharmakon1600-01500180; CHLOROTHIAZIDE [GREEN BOOK]; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; HY-B0224; MSK10325; CHLOROTHIAZIDE [EP IMPURITY]; CHLOROTHIAZIDE [ORANGE BOOK]; Tox21_110107; Tox21_200972; Tox21_500254; WLN: T66 BSWM ENJ HG ISZW; CCG-38953; CHLOROTHIAZIDE [USP IMPURITY]; EBC-08326; EBC-26505; NSC756682; s1641; CHLOROTHIAZIDE [USP MONOGRAPH]; AKOS015896601; AKOS024319450; Tox21_110107_1; DB00880; FC20399; LP00254; NC00500; NSC-756682; SDCCGSBI-0050242.P005; IDI1_000675; NCGC00015242-01; NCGC00015242-02; NCGC00015242-03; NCGC00015242-05; NCGC00015242-06; NCGC00015242-07; NCGC00015242-08; NCGC00015242-09; NCGC00015242-10; NCGC00015242-12; NCGC00015242-13; NCGC00015242-18; NCGC00015242-19; NCGC00091042-01; NCGC00091042-02; NCGC00091042-03; NCGC00091042-04; NCGC00091042-05; NCGC00258525-01; NCGC00260939-01; AC-18732; AS-11760; DA-51859; SBI-0050242.P004; C2259; EU-0100254; Hydrochlorothiazide impurity, chlorothiazide-; NS00000586; SW219268-1; Chlorothiazide 100 microg/mL in Acetonitrile; C07461; D00519; D89501; AB00051940-04; AB00051940_05; AB00051940_06; Hydrochlorothiazide EP Impurity A; Chlorothiazide; F814386; HYDROCHLOROTHIAZIDE IMPURITY A [EP IMPURITY]; Q2603363; SR-01000075604-1; SR-01000075604-3; SR-01000075604-5; BRD-K88682005-001-05-9; BRD-K88682005-001-07-5; BRD-K88682005-001-15-8; BRD-K88682005-001-16-6; Z1501480416; 6-Chloro-7-sulfamoyl-2H-1,4-benzothiadiazine 1,1-dioxide; 6-Chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide; 6-Chloro-2H-1,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-chloro-4H-1,2,4-benzathiadiazine-7-sulfonamide-1,1-dioxide; Chlorothiazide, European Pharmacopoeia (EP) Reference Standard; 2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; 6-chloro-1,1-dioxo-2H-1lambda,2,4-benzothiadiazine-7-sulfonamide; 6-chloro-1,1-dioxo-4H-1$l^{6,2,4-benzothiadiazine-7-sulfonamide; Chlorothiazide, United States Pharmacopeia (USP) Reference Standard; HYDROCHLOROTHIAZIDE IMPURITY, CHLOROTHIAZIDE- [USP IMPURITY]; 6-Chloro-1,1-dioxo-1,4-dihydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide; Chlorothiazide, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyme
